ObjectiveThe aim of this study was to investigate (a) macrophage migration inhibitory factor (MIF) levels in polytrauma patients and rats after haemorrhagic shock (HS), (b) the potential of the MIF inhibitor ISO-1 to reduce multiple organ dysfunction syndrome (MODS) in acute (short-term and long-term follow-up) HS rat models and (c) whether treatment with ISO-1 attenuates NF-kappa B and NLRP3 activation in HS. BackgroundThe MODS caused by an excessive systemic inflammatory response following trauma is associated with a high morbidity and mortality. MIF is a pleiotropic cytokine which can modulate the inflammatory response, however, its role in trauma is unknown. MethodsThe MIF levels in plasma of polytrauma patients and serum of rats with HS were measured by ELISA. Acute HS rat models were performed to determine the influence of ISO-1 on MODS. The activation of NF-kappa B and NLRP3 pathways were analysed by western blot in the kidney and liver. ResultsWe demonstrated that (a) MIF levels are increased in polytrauma patients on arrival to the emergency room and in rats after HS, (b) HS caused organ injury and/or dysfunction and hypotension (post-resuscitation) in rats, while (c) treatment of HS-rats with ISO-1 attenuated the organ injury and dysfunction in acute HS models and (d) reduced the activation of NF-kappa B and NLRP3 pathways in the kidney and liver. ConclusionOur results point to a role of MIF in the pathophysiology of trauma-induced organ injury and dysfunction and indicate that MIF inhibitors may be used as a potential therapeutic approach for MODS after trauma and/or haemorrhage.

Inhibition of Macrophage Migration Inhibitory Factor Activity Attenuates Haemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats

Collino, Massimo;Collotta, Debora;Alves, Gustavo Ferreira;
2022-01-01

Abstract

ObjectiveThe aim of this study was to investigate (a) macrophage migration inhibitory factor (MIF) levels in polytrauma patients and rats after haemorrhagic shock (HS), (b) the potential of the MIF inhibitor ISO-1 to reduce multiple organ dysfunction syndrome (MODS) in acute (short-term and long-term follow-up) HS rat models and (c) whether treatment with ISO-1 attenuates NF-kappa B and NLRP3 activation in HS. BackgroundThe MODS caused by an excessive systemic inflammatory response following trauma is associated with a high morbidity and mortality. MIF is a pleiotropic cytokine which can modulate the inflammatory response, however, its role in trauma is unknown. MethodsThe MIF levels in plasma of polytrauma patients and serum of rats with HS were measured by ELISA. Acute HS rat models were performed to determine the influence of ISO-1 on MODS. The activation of NF-kappa B and NLRP3 pathways were analysed by western blot in the kidney and liver. ResultsWe demonstrated that (a) MIF levels are increased in polytrauma patients on arrival to the emergency room and in rats after HS, (b) HS caused organ injury and/or dysfunction and hypotension (post-resuscitation) in rats, while (c) treatment of HS-rats with ISO-1 attenuated the organ injury and dysfunction in acute HS models and (d) reduced the activation of NF-kappa B and NLRP3 pathways in the kidney and liver. ConclusionOur results point to a role of MIF in the pathophysiology of trauma-induced organ injury and dysfunction and indicate that MIF inhibitors may be used as a potential therapeutic approach for MODS after trauma and/or haemorrhage.
2022
13
1
13
ISO-1; haemorrhagic shock; ischaemia-reperfusion; macrophage migration inhibitory factor; multiple organ dysfunction syndrome; trauma; Animals; Humans; Multiple Organ Failure; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Macrophage Migration-Inhibitory Factors; Multiple Trauma; Shock, Hemorrhagic
Patel, Nikita M; Yamada, Noriaki; Oliveira, Filipe R M B; Stiehler, Lara; Zechendorf, Elisabeth; Hinkelmann, Daniel; Kraemer, Sandra; Stoppe, Christian; Collino, Massimo; Collotta, Debora; Alves, Gustavo Ferreira; Ramos, Hanna Pillmann; Sordi, Regina; Marzi, Ingo; Relja, Borna; Marx, Gernot; Martin, Lukas; Thiemermann, Christoph
File in questo prodotto:
File Dimensione Formato  
2022 Frontiers in Immunol HS ISO1.pdf

Accesso aperto

Descrizione: PDF EDITORIALE
Tipo di file: PDF EDITORIALE
Dimensione 2.55 MB
Formato Adobe PDF
2.55 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1876519
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 4
social impact